Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples